Rosa & Co. Participated in the 2016 Roche Quantitative Systems Pharmacology (QSP) Methodology Workshop

Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in PhysioPD/QSP, today announced their participation at the 2016 Roche QSP Methodology Workshop held on February 4 & 5th, 2016 in Basel, Switzerland.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

In recent years, QSP has emerged as a powerful research approach that enables scientific insight and informs early discovery to clinical development decisions. The most innovative R&D organizations in the industry are increasingly adopting QSP as an essential research component for more informed decision-making. ConstantiaRosa's participation in this workshop further demonstrates its commitment to expanding the adoption of QSP into a standard research method used within the pharmaceutical industry.

Dr. Christina Friedrich, Chief Engineer at Rosa, recently published an article on QSP model qualification, and participated in the workshop that brought together key opinion leaders from industry and academia to make a substantive contribution toward even broader implementation of QSP. The workshop capitalized on the group's accumulated experience and applications to review and discuss evolving methodologies in the field.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?